Royalty Pharma Appoints Dr. Ted W. Love As Lead Independent Director
Provided By GlobeNewswire
Last update: Sep 29, 2025
NEW YORK, Sept. 29, 2025 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced that the independent directors of the Board have unanimously appointed Dr. Ted W. Love, an independent director since 2020, as Lead Independent Director. Dr. Love will continue to Chair the Nominating and Corporate Governance Committee.
Read more at globenewswire.com
